Forecast for NINDS Exploratory Grant Program in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Research (P20 - Clinical Trial Optional)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is set to announce a funding opportunity for the NINDS Exploratory Grant Program focused on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) research, utilizing the P20 activity code. This initiative aims to foster the establishment of new collaborative research teams to tackle pressing issues in ME/CFS, encouraging applications from investigators with relevant expertise, particularly those exploring post-infectious chronic illnesses. The estimated total program funding is $3 million, with approximately six awards expected, and interested applicants should prepare for the application process, which is anticipated to open with a synopsis posted on October 1, 2025, and close on February 25, 2026. For further inquiries, potential applicants can contact Dr. Vicky Whittemore at vicky.whittemore@nih.gov or by phone at 240-274-6696.
Eligible Applicants
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grant Policy Statement, are allowed.